Skip to main content

Refractory splenectomized immune thrombocytopenic purpura: Does vincristine have a role after thrombopoietin receptor agonist failure?

مؤلف البحث
Sawsan M Moeen, Ahmad F Thabet, Mohamed A Morad
تاريخ البحث
مجلة البحث
The Egyptian Journal of Haematology
المشارك في البحث
الناشر
Medknow
عدد البحث
Volume 47, Issue 4
موقع البحث
https://scholar.google.com/scholar?oi=bibs&cluster=226425586651640466&btnI=1&hl=en
سنة البحث
2022
صفحات البحث
299-303
ملخص البحث

Objective

This study was done to assess the efficacy of vincristine in the treatment of patients with splenectomized chronic ITP who failed TPO-RA therapy as well as their 8-month follow-up following vincristine discontinuation.